Contributions
Abstract: 77
Type: Oral
The practice of medicine and the delivery of health care are undergoing transformation; value-based care is at the heart of this transformation. The effective utilization of technology across the continuum of chronic disease is an essential element in facilitating this transformation. The exponential growth in processing speed and capabilities of mobile devices coupled with their affordability and availability make mobile applications (Apps) ideally suited to be integrated into clinical care of monitoring chronic neurological disease. From a technology perspective, the past 5 years has been termed “the 'appification' of everything,” including medicine. The Cleveland Clinic has been utilizing internally developed apps to aid in the care of MS patients for the past three years. Apps have been developed through rigorous scientific validation while incorporating patient centered design principles. The MSPT app consists of assessment modules to evaluate the most important clinical manifestations of MS: manual dexterity, gait, contrast sensitivity, information processing speed and overall quality of life. To date, more than 3,000 unique patients have completed nearly 5,000 MSPT assessments as part of their medical appointment. The data characterizing motor and executive function for each patient are summarized and integrated into the patient's electronic health record. Performance on each evaluation module is expressed over time and the physician can review and share with the patient. An important aspect of the successful deployment of the technology was the active involvement of a multi-disciplinary team consisting of patients, administrative staff, facilities and engineering, marketing, physicians, nursing, researchers and software engineers. This project represents the future of integrated healthcare and research systems by utilizing and deploying validated mobile technology to characterize important aspects of MS patient function to facilitate large-scale data collection to improve patient-specific clinical care and accelerate scientific understanding of the disease and potential interventions.
Disclosure: Jay L. Alberts has received funding from National Institutes of Health, Department of Defense, National Science Foundation and Biogen to support the development and validation of mobile technology for mild traumatic brain injury, Parkinson´s disease and MS.
Abstract: 77
Type: Oral
The practice of medicine and the delivery of health care are undergoing transformation; value-based care is at the heart of this transformation. The effective utilization of technology across the continuum of chronic disease is an essential element in facilitating this transformation. The exponential growth in processing speed and capabilities of mobile devices coupled with their affordability and availability make mobile applications (Apps) ideally suited to be integrated into clinical care of monitoring chronic neurological disease. From a technology perspective, the past 5 years has been termed “the 'appification' of everything,” including medicine. The Cleveland Clinic has been utilizing internally developed apps to aid in the care of MS patients for the past three years. Apps have been developed through rigorous scientific validation while incorporating patient centered design principles. The MSPT app consists of assessment modules to evaluate the most important clinical manifestations of MS: manual dexterity, gait, contrast sensitivity, information processing speed and overall quality of life. To date, more than 3,000 unique patients have completed nearly 5,000 MSPT assessments as part of their medical appointment. The data characterizing motor and executive function for each patient are summarized and integrated into the patient's electronic health record. Performance on each evaluation module is expressed over time and the physician can review and share with the patient. An important aspect of the successful deployment of the technology was the active involvement of a multi-disciplinary team consisting of patients, administrative staff, facilities and engineering, marketing, physicians, nursing, researchers and software engineers. This project represents the future of integrated healthcare and research systems by utilizing and deploying validated mobile technology to characterize important aspects of MS patient function to facilitate large-scale data collection to improve patient-specific clinical care and accelerate scientific understanding of the disease and potential interventions.
Disclosure: Jay L. Alberts has received funding from National Institutes of Health, Department of Defense, National Science Foundation and Biogen to support the development and validation of mobile technology for mild traumatic brain injury, Parkinson´s disease and MS.